Clinical Trial Update: Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating perioperative chemotherapy plus trastuzumab and toripalimab for HER2-positive locally advanced gastric or esophagogastric junc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of Esophagogastric Junction
• Adenocarcinoma of the Stomach

Drugs mentioned

• Toripalimab (Toripalimab)
• Trastuzumab (Herceptin) (trastuzumab)

Snippet

Sponsor: Yu jiren | Conditions: Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction | Phase 2 | Status: RECRUITING